Nadja Leimer

773 total citations
14 papers, 546 citations indexed

About

Nadja Leimer is a scholar working on Infectious Diseases, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, Nadja Leimer has authored 14 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Molecular Biology and 5 papers in Clinical Biochemistry. Recurrent topics in Nadja Leimer's work include Antimicrobial Resistance in Staphylococcus (8 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Bacterial biofilms and quorum sensing (5 papers). Nadja Leimer is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (8 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Bacterial biofilms and quorum sensing (5 papers). Nadja Leimer collaborates with scholars based in Switzerland, United States and Belgium. Nadja Leimer's co-authors include Annelies S. Zinkernagel, Clément Vulin, Markus Huemer, Martin J. Loessner, Martin Ackermann, Kati Seidl, Lars Fieseler, Brion Duffy, Yannick Born and Fritz Eichenseher and has published in prestigious journals such as Nature Communications, PLoS ONE and Applied and Environmental Microbiology.

In The Last Decade

Nadja Leimer

13 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nadja Leimer Switzerland 11 272 178 155 98 90 14 546
Romain Guérillot Australia 12 259 1.0× 95 0.5× 224 1.4× 85 0.9× 69 0.8× 23 487
Peter Chahales United States 6 249 0.9× 358 2.0× 119 0.8× 100 1.0× 150 1.7× 6 575
Assaf Raz United States 14 303 1.1× 384 2.2× 205 1.3× 102 1.0× 196 2.2× 19 744
Anu Daniel United States 5 204 0.8× 218 1.2× 172 1.1× 59 0.6× 123 1.4× 6 433
Derek Pickard United Kingdom 13 344 1.3× 265 1.5× 142 0.9× 93 0.9× 108 1.2× 17 770
Patricia Sanchez‐Carballo Germany 13 341 1.3× 133 0.7× 293 1.9× 83 0.8× 94 1.0× 21 844
Virginie Libante France 14 287 1.1× 111 0.6× 109 0.7× 155 1.6× 40 0.4× 18 573
Geeta Ram United States 15 460 1.7× 398 2.2× 214 1.4× 168 1.7× 106 1.2× 20 702
Xin Tan China 11 226 0.8× 117 0.7× 94 0.6× 42 0.4× 80 0.9× 28 420
Tamta Tkhilaishvili Germany 14 245 0.9× 431 2.4× 108 0.7× 47 0.5× 220 2.4× 17 671

Countries citing papers authored by Nadja Leimer

Since Specialization
Citations

This map shows the geographic impact of Nadja Leimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadja Leimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadja Leimer more than expected).

Fields of papers citing papers by Nadja Leimer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadja Leimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadja Leimer. The network helps show where Nadja Leimer may publish in the future.

Co-authorship network of co-authors of Nadja Leimer

This figure shows the co-authorship network connecting the top 25 collaborators of Nadja Leimer. A scholar is included among the top collaborators of Nadja Leimer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadja Leimer. Nadja Leimer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Shrestha, Muskan, et al.. (2025). Hygromycin A Treatment of Borrelia burgdorferi –Infected Peromyscus leucopus Suggests Potential as a Reservoir-Targeted Antibiotic. The Journal of Infectious Diseases. 233(1). 96–100.
2.
Leimer, Nadja, Egor A. Syroegin, Zackery P. Bulman, et al.. (2023). Structural insights into the mechanism of overcoming Erm-mediated resistance by macrolides acting together with hygromycin-A. Nature Communications. 14(1). 4196–4196. 21 indexed citations
3.
Huemer, Markus, Srikanth Mairpady Shambat, Nadja Leimer, et al.. (2020). Targeting Hidden Pathogens: Cell-Penetrating Enzybiotics Eradicate Intracellular Drug-Resistant Staphylococcus aureus. mBio. 11(2). 66 indexed citations
4.
Haunreiter, Vanina Dengler, Mathilde Boumasmoud, Nadja Leimer, et al.. (2019). In-host evolution of Staphylococcus epidermidis in a pacemaker-associated endocarditis resulting in increased antibiotic tolerance. Nature Communications. 10(1). 1149–1149. 68 indexed citations
5.
Vulin, Clément, Nadja Leimer, Markus Huemer, Martin Ackermann, & Annelies S. Zinkernagel. (2018). Prolonged bacterial lag time results in small colony variants that represent a sub-population of persisters. Nature Communications. 9(1). 4074–4074. 112 indexed citations
6.
Born, Yannick, et al.. (2017). Engineering of Bacteriophages Y2:: dpoL1-C and Y2:: luxAB for Efficient Control and Rapid Detection of the Fire Blight Pathogen, Erwinia amylovora. Applied and Environmental Microbiology. 83(12). 74 indexed citations
7.
Seidl, Kati, et al.. (2016). High level methicillin resistance correlates with reduced Staphylococcus aureus endothelial cell damage. International Journal of Medical Microbiology. 307(1). 11–20. 6 indexed citations
8.
Achermann, Yvonne, Kati Seidl, Stefan P. Kuster, et al.. (2015). Epidemiology of Methicillin-SusceptibleStaphylococcus aureusin a Neonatology Ward. Infection Control and Hospital Epidemiology. 36(11). 1305–1312. 17 indexed citations
9.
Seidl, Kati, et al.. (2015). Clonality and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus at the University Hospital Zurich, Switzerland between 2012 and 2014. Annals of Clinical Microbiology and Antimicrobials. 14(1). 14–14. 26 indexed citations
10.
Leimer, Nadja, Fritz Eichenseher, Kati Seidl, et al.. (2015). NonstableStaphylococcus aureusSmall-Colony Variants Are Induced by Low pH and Sensitized to Antimicrobial Therapy by Phagolysosomal Alkalinization. The Journal of Infectious Diseases. 213(2). 305–313. 64 indexed citations
11.
Sauteur, Patrick M. Meyer, Nadja Leimer, Christa Relly, et al.. (2015). Methicillin‐resistant Staphylococcus aureus eradication in young infants should include the diaper area and treat housing contacts. Acta Paediatrica. 104(12). e581–4. 2 indexed citations
12.
Seidl, Kati, et al.. (2014). USA300 methicillin-resistant Staphylococcus aureus in Zurich, Switzerland between 2001 and 2013. International Journal of Medical Microbiology. 304(8). 1118–1122. 14 indexed citations
13.
Bossche, An Van den, Pieter‐Jan Ceyssens, Jeroen De Smet, et al.. (2014). Systematic Identification of Hypothetical Bacteriophage Proteins Targeting Key Protein Complexes of Pseudomonas aeruginosa. Journal of Proteome Research. 13(10). 4446–4456. 52 indexed citations
14.
Stiefel, Philipp, Rainer Follador, Nadja Leimer, et al.. (2012). Reactive Oxygen Species-Inducible ECF σ Factors of Bradyrhizobium japonicum. PLoS ONE. 7(8). e43421–e43421. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026